A Mid-Cap Opportunity In “Wet AMD”
The company’s drug for wet AMD had proven to help with the disorder, and thus it seems highly likely it will be approved.
Biotech Investor
The company’s drug for wet AMD had proven to help with the disorder, and thus it seems highly likely it will be approved.